跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BORTESUN POWDER FOR SOLUTION FOR INJECTION 3.5 MG/ VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
BORTESUN POWDER FOR SOLUTION FOR INJECTION 3.5 MG/ VIAL
Approved
THERAPEUTIC
BORTESUN POWDER FOR SOLUTION FOR INJECTION 3.5 MG/ VIAL
SUN PHARMACEUTICAL INDUSTRIES LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Dec 10, 2018
Approval ID
95d0b1f0c6161fda
Company
SUN PHARMACEUTICAL INDUSTRIES LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
95d0b1f0c6161fda
Drug Name
BORTESUN POWDER FOR SOLUTION FOR INJECTION 3.5 MG/ VIAL
Product Name
BORTESUN POWDER FOR SOLUTION FOR INJECTION 3.5 MG/ VIAL
Approval Number
SIN15594P
Approval Date
2018-12-10
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Licence Holder
RANBAXY (MALAYSIA) SDN. BHD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS, SUBCUTANEOUS
Atc Code
L01XX32
Atc Item Name
xl 01 xx 32
Pharma Manufacturer Name
RANBAXY (MALAYSIA) SDN. BHD.
Active Ingredients
BORTEZOMIB
3.5mg/vial
BORTEZOMIB
3.5mg/vial
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 10, 2018
Approval ID
95d0b1f0c6161fda
Type
Therapeutic
Back to HSA Approvals
